Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Publications

Search Items: JANUS KINASE 2 - GENETICS , . hits: 10

2018

Burgstaller, S; Buxhofer-Ausch, V; Sliwa, T; Beham-Schmid, C; Gastl, G; Geissler, K; Melchardt, T; Krauth, M; Krippl, P; Petzer, A; Rumpold, H; Wölfler, A; Gisslinger, H Austrian recommendations for the management of polycythemia vera.
Wien Klin Wochenschr. 2018; 130(17-18):535-542 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2017

Jeryczynski, G; Thiele, J; Gisslinger, B; Wölfler, A; Schalling, M; Gleiß, A; Burgstaller, S; Buxhofer-Ausch, V; Sliwa, T; Schlögl, E; Geissler, K; Krauth, MT; Nader, A; Vesely, M; Simonitsch-Klupp, I; Müllauer, L; Beham-Schmid, C; Gisslinger, H Pre-fibrotic/early primary myelofibrosis vs. WHO-defined essential thrombocythemia: The impact of minor clinical diagnostic criteria on the outcome of the disease.
Am J Hematol. 2017; 92(9):885-891 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2016

Themanns, M; Mueller, KM; Kessler, SM; Golob-Schwarzl, N; Mohr, T; Kaltenecker, D; Bourgeais, J; Paier-Pourani, J; Friedbichler, K; Schneller, D; Schlederer, M; Zebedin-Brandl, E; Terracciano, LM; Han, X; Kenner, L; Wagner, KU; Mikulits, W; Kozlov, AV; Heim, MH; Gouilleux, F; Haybaeck, J; Moriggl, R Hepatic Deletion of Janus Kinase 2 Counteracts Oxidative Stress in Mice.
Sci Rep. 2016; 6(4):34719-34719 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2014

Vytrva, N; Stacher, E; Regitnig, P; Zinke-Cerwenka, W; Hojas, S; Hubmann, E; Porwit, A; Bjorkholm, M; Hoefler, G; Beham-Schmid, C Megakaryocytic morphology and clinical parameters in essential thrombocythemia, polycythemia vera, and primary myelofibrosis with and without JAK2 V617F.
Arch Pathol Lab Med. 2014; 138(9):1203-1209 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2010

Will, B; Siddiqi, T; Alberich Jordà, M; Shimamura, T; Luptakova, K; Staber, PB; Costa, DB; Steidl, U; Tenen, DG; Kobayashi, S Apoptosis induced by JAK2 inhibition is mediated by Bim and enhanced by the BH3 mimetic ABT-737 in JAK2 mutant human erythroid cells.
Blood. 2010; 115(14):2901-2909 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2009

Gattenlohner, S; Serfling, E; Einsele, H; Muller-Hermelink, HK Molecular insights into the morphology of myeloproliferative neoplasms using an in situ PCR assay specific for the JAK2 mutation V617F.
Leukemia. 2009; 23(1):196-199 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Gattenlohner, S; Volker, HU; Etschmann, B; Einsele, H; Muller-Hermelink, HK BCR-ABL positive chronic myeloid leukemia with concurrent JAK2(V617F) positive myelodysplastic syndrome/myeloproliferative neoplasm (RARS-T).
Am J Hematol. 2009; 84(5):306-307 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

2008

Gattenlohner, S; Ertl, G; Einsele, H; Kircher, S; Muller-Hermelink, HK; Marx, A Cardiac JAK2 mutation V617F in a patient with cardiomyopathy and myeloproliferative disease.
Ann Intern Med. 2008; 149(1):69-71 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Pasqualucci, L; Li, S; Meloni, G; Schnittger, S; Gattenlohner, S; Liso, A; Di Ianni, M; Martelli, MP; Pescarmona, E; Foa, R; Haferlach, T; Skoda, RC; Falini, B NPM1-mutated acute myeloid leukaemia occurring in JAK2-V617F+ primary myelofibrosis: de-novo origin?
Leukemia. 2008; 22(7):1459-1463 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2007

Gattenlohner, S; Peter, C; Bonengel, M; Einsele, H; Bargou, R; Muller-Hermelink, HK; Marx, A Detecting the JAK2 V617F mutation in fresh and 'historic' blood and bone marrow.
Leukemia. 2007; 21(7):1599-1602 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

© Med Uni GrazImprint